Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.
Katinka Van de Ven, Lisa Maher, Handan Wand, Sonja Memedovic, Eva Jackson, Jenny Iversen
Author Information
Katinka Van de Ven: Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia. ORCID
Lisa Maher: The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia. ORCID
Handan Wand: The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia. ORCID
Sonja Memedovic: Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Eva Jackson: Nepean Blue Mountains Local Health District, NSW Ministry of Health, Sydney, Australia.
Jenny Iversen: The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia. ORCID
INTRODUCTION AND AIMS: People who use performance and image enhancing drugs (PIED) are a growing population in needle syringe programs (NSP) in Australia. Previous international research has identified heterogeneity among the PIED-using population. This study investigated health behaviours among NSP attendees who had recently (last 12 months) injected PIEDs and examined differences among this group according to recent psychoactive drug use. DESIGN AND METHODS: The Australian Needle and Syringe Program Survey is an annually repeated cross-sectional survey conducted at approximately 50 NSPs nationally. In 2015, respondents provided information on their demographic characteristics, health risk and health monitoring behaviours, and provided a capillary dried blood spot for HIV and hepatitis C virus antibody testing. Univariable and multivariable logistic regressions assessed factors associated with recent (last 12 months) use (all routes of administration) of psychoactive drugs. RESULTS: Among recent PIED injectors (n = 156), 59% had recently used psychoactive substances. Those who had recently used psychoactive drugs were significantly younger, less educated and more likely to have experienced redness at an injection site in the previous 12 months but were more likely to report recent HIV/hepatitis C virus testing. DISCUSSION AND CONCLUSIONS: This study identified significant differences in demographic characteristics, risk and health seeking behaviour among PIED users who did and did not also use psychoactive substances. There is a need to enhance and tailor harm reduction efforts and to build the capacity of NSP staff to better meet the needs of this diverse group.
